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ABSTRACT Osteomyelitis (OM), or inflammation of bone tissue, occurs most fre-
quently as a result of bacterial infection and severely perturbs bone structure. OM is
predominantly caused by Staphylococcus aureus, and even with proper treatment,
OM has a high rate of recurrence and chronicity. While S. aureus has been shown to
infect osteoblasts, it remains unclear whether osteoclasts (OCs) are also a target of
intracellular infection. Here, we demonstrate the ability of S. aureus to intracellularly
infect and divide within OCs. OCs were differentiated from bone marrow macro-
phages (BMMs) by exposure to receptor activator of nuclear factor kappa-B ligand
(RANKL). By utilizing an intracellular survival assay and flow cytometry, we found
that at 18 h postinfection the intracellular burden of S. aureus increased dramatically
in cells with at least 2 days of RANKL exposure, while the bacterial burden decreased
in BMMs. To further explore the signals downstream of RANKL, we manipulated fac-
tors controlling OC differentiation, NFATc1 and alternative NF-B, and found that in-
tracellular bacterial growth correlates with NFATc1 levels in RANKL-treated cells.
Confocal and time-lapse microscopy in mature OCs showed a range of intracellular
infection that correlated inversely with S. aureus-phagolysosome colocalization. The
propensity of OCs to become infected, paired with their diminished bactericidal ca-
pacity compared to BMMs, could promote OM progression by allowing S. aureus to
evade initial immune regulation and proliferate at the periphery of lesions where
OCs are most abundant.
IMPORTANCE The inflammation of bone tissue is called osteomyelitis, and most
cases are caused by an infection with the bacterium Staphylococcus aureus. To date,
the bone-building cells, osteoblasts, have been implicated in the progression of
these infections, but not much is known about how the bone-resorbing cells, oste-
oclasts, participate. In this study, we show that S. aureus can infect osteoclasts and
proliferate inside these cells, whereas bone-residing macrophages, immune cells re-
lated to osteoclasts, destroy the bacteria. These findings elucidate a unique role for
osteoclasts to harbor bacteria during infection, providing a possible mechanism by
which bacteria could evade destruction by the immune system.
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intracellular bacteria
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Although osteomyelitis (OM) technically refers to the inflammation of the marrowcavity, it is most frequently used to indicate infection of the bone itself. At the
center of infectious OM lesions, bone is frequently lost by necrosis, forming a devas-
cularized segment of bone known as a sequestrum. Osteoclasts (OCs) are recruited to
the site via inflammatory cytokine release and expand the area of bone loss. New bone
is formed on the periosteum in the body’s attempt to isolate the infection, generating
an involucrum. Thus, the normal balance between bone formation and resorption is
disrupted in OM, leading to pathological fractures and deformities (1). Compared to
other tissues, bone infections are especially damaging and intractable, with treatment
often involving prolonged antibiotics paired with surgical debridement (2). However,
even with proper treatment, OM has a high recurrence rate, leading to a chronic
debilitating condition (3, 4). OM is predominantly divided into two broad categories: (i)
acute hematogenous OM caused by bacteria seeding directly into bone from the
circulation, and (ii) secondary OM originating from a contiguous source like a soft tissue
infection or orthopedic implant or following open fracture (1, 5). Acute hematogenous
OM is most common in children, with 85% of cases occurring in children under 17 years
of age, whereas secondary OM infections are more common in older adults, especially
those undergoing orthopedic surgery (5, 6), and they account for a projected cost of
more than $1 billion dollars annually in the United States (7). Regardless of the type of
OM, most cases are caused by Staphylococcus aureus (6, 8).
Despite the clinical significance of OM infections, there remains a dearth of knowl-
edge as to the mechanisms underlying the etiopathology of the disease. Patient-
centered studies have demonstrated the paramount role of biofilms in seeding im-
plants and driving the subsequent chronicity and intractability of the infections (7, 9).
Similar studies have examined the localization of bacteria in the bone tissue, including
within osteoblasts, osteocytes, and bone canaliculi, and characteristics of the inflam-
matory response initiated by infection (10–13). At this point, most of the basic science
work on OM has focused on characterizing changes to the structure of the bone (10,
14–16), elucidating bacterial survival strategies (17, 18), or examining the role of
osteoblasts in promoting infection (17, 19–21). In vitro, S. aureus has the ability to infect
osteoblasts, persist intracellularly, and induce the release of osteoclastogenic and
inflammatory cytokines (15, 19, 20, 22). While it is not clear how many osteoblasts in an
OM lesion harbor intracellular bacteria in vivo, cytokines are produced locally (23–28).
Investigation into the role of OCs in OM has focused mainly on determining the effects
of S. aureus infection on bone resorption, often overlooking whether OCs could also be
a direct target of infection (29–32).
OCs are differentiated from the myeloid lineage in a process that involves receptor
activator of nuclear factor kappa-B ligand (RANKL) signaling to alternative NF-B
signaling through NF-B-inducing kinase (NIK) and RelB, activating NFATc1 (33–35).
However, despite their shared lineage, OCs show a decreased release of inflammatory
cytokines and nitric oxide when challenged with bacteria compared to macrophages
(31). Most macrophages attempt to destroy internalized S. aureus via acidification of the
phagolysosome, digestive hybrid organelles formed upon fusion of phagosomes with
phagolysosomes (36). However, S. aureus has been shown to persist within some
peripheral macrophages through intraphagolysosomal replication and escape (37, 38).
Yet, the ability of OCs to control S. aureus infection is not known. In this study, we show
that S. aureus is not only able to infect OCs but also proliferates within them, avoiding
lysosomal compartments. This study illuminates a novel function of OCs in OM as an
intracellular reservoir allowing bacterial proliferation, in addition to their ability to
modulate bone structure through perturbed remodeling.
RESULTS
S. aureus resides within osteoclasts in vivo and in vitro. Although previous
studies have shown that S. aureus invasion of osteoblasts leads to RANKL expression
and robust OC recruitment at sites of bone infection, it remains unclear whether OCs
are cellular targets for intracellular infection. To demonstrate the intracellular presence
Krauss et al. ®
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of S. aureus within OCs in vivo, we injected green fluorescent protein (GFP)-expressing
S. aureus (USA300 lineage strain LAC) subcutaneously over the periosteum of calvaria
in TRAP-tdTomato (herein referred as TRAPRed) reporter mice (39). Prior to microbial
challenge, RANKL was injected daily over the calvaria for 5 days to recruit OCs and their
precursors to the subsequent site of infection. At 24 h postinfection (hpi), calvaria were
harvested, and histological sections were examined by confocal microscopy to visualize
bacteria residing within OCs, since both are fluorescently labeled. As shown in Fig. 1A,
GFP-expressing S. aureus can clearly be found localized within TRAPRed OCs. Murine OCs
were also generated on bone slices in vitro, then infected with GFP-labeled S. aureus,
and treated with gentamicin to destroy extracellular bacteria. The cells were imaged
18 h later, and bacteria were again found intracellularly within OCs (Fig. 1B).
In order to demonstrate whether the observed intracellular bacteria were viable, we
used a gentamicin-based protection assay. Murine bone marrow macrophages (BMMs)
were differentiated with RANKL for up to 3 days (Fig. 1C) and infected with S. aureus for
30 min at a multiplicity of infection (MOI) of 1:1, after which extracellular bacteria were
killed by the addition of gentamicin for 1 h. Infected cells were lysed after 16.5 h of
additional culture (at 18 hpi), and CFU were enumerated. While exposure of BMMs to
RANKL for 1 day had no effect on the number of bacteria recovered, 2 days of
differentiation in RANKL (lineage-committed TRAP-positive [TRAP] preosteoclasts
[pre-OCs]) led to 100-fold-increased bacterial load, and 3 days of RANKL (fully differ-
entiated OCs) caused an 500-fold change, compared to no RANKL (undifferentiated
BMMs) (Fig. 1D). In order to preclude any confounding effects that may be specific to
gentamicin treatment in our assay, we repeated the 18 hpi CFU assay during OC
differentiation with lysostaphin as the bactericidal agent instead of gentamicin. We
found that the patterns of increased intracellular bacterial load in OCs at 18 hpi were
the same in our lysostaphin protection assay as with our gentamicin protection assay
(see Fig. S1 in the supplemental material).
FIG 1 S. aureus resides within osteoclasts (OCs) in vivo and in vitro. (A) Confocal microscopy of histological sections reveals
internalized GFP S. aureus inside TRAPRed OCs within mouse calvarium (yellow puncta) 24 h postinfection (hpi). (B) OCs
differentiated from bone marrow macrophages (BMMs) with 3 days of RANKL and M-CSF on devitalized bone, infected, and
treated with gentamicin also harbor S. aureus (green puncta) 18 hpi. (C) TRAP staining of BMMs differentiated toward OCs for
up to 3 days showing multiple TRAP mononuclear cells at day 2 (D2) and numerous TRAP multinuclear fully differentiated
OCs at D3. (D) Enumerated CFU grown on tryptic soy agar from lysates of BMMs differentiated toward OCs for up to 3 days
and infected with S. aureus for 18 h, with gentamicin killing of extracellular bacteria. Values that are significantly different from
the values at D0 by one-way ANOVA with Tukey’s posthoc test are indicated as follows: ****, P  0.0001. n 3 technical
replicates, representative of 5 biological replicates.
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S. aureus proliferates within osteoclasts in vitro. BMMs have innate immune
activity and have previously been shown to phagocytose and kill intracellular bacteria
(36). Using the gentamicin protection assay, we confirmed that our BMMs behave
similarly, finding that the number of intracellular S. aureus at 18 hpi is 10-fold lower
than at 1.5 hpi, immediately after removal of extracellular bacteria by antibiotic
treatment (Fig. 2A, day 0 [D0]). In contrast, bacterial recovery from RANKL-treated
cultures (day 2 [D2] or day 3 [D3]) demonstrated a dramatic increase between 1.5 and
18 hpi, suggesting that S. aureus can proliferate within OCs. There was no difference in
the ability of any of the cultures to internalize S. aureus, as the 1.5 hpi bacterial counts
were similar across groups. In order to rule out potential differential effects of OCs
FIG 2 S. aureus proliferates within OCs in vitro in a RANKL-induced Osteoclastogenesis-dependent manner. BMMs were treated with RANKL for up to 3 days
and subjected to the gentamicin protection assay. (A) CFU from lysates of infected cells after OC differentiation for 0, 2, or 3 days. Cells were lysed immediately
after gentamicin exposure (1.5 hpi) or after an additional 16.5 h in osteoclastogenic media (D2, D3) or control media (D0). n 3 technical replicates,
representative of5 biological replicates. (B) CFU from lysates of infected human CD14monocytes isolated from peripheral blood and differentiated into OCs
for 3 days before infection. n 3 biological replicates. (C) CFU from lysates of infected BMMs after exposure for 2 days to either PBS, RANKL, IFN-, or IL-4. n 3
technical replicates, representative of 3 biological replicates. (D) BMMs harvested from NFATc1 conditional knockout animals (cKO) show no basal (D0) or
induced (D2) NFATc1 protein by Western blotting compared to littermate control mice BMMs (Ctrl). (E) TRAP staining after 3 days of RANKL exposure
demonstrates failure of NFATc1-cKO BMMs to form TRAP multinuclear OCs. (F) CFU from lysates of Ctrl or NFATc1 cKO BMMs differentiated into OCs for 0
or 2 days and subjected to the gentamicin protection assay. All bars represent 18 h postinfection (hpi). White bars, Ctrl; black bars, NFATc1 cKO cells. (G) CFU
from lysates of wild-type (WT) BMMs transfected with empty vector (pMX-EV [white bars]) or NFATc1-overexpressing vector (pMX-NFAT [black bars]) at 18 hpi,
showing positive effect of NFATc1 at D2. (H) Rosiglitazone treatment of WT BMMs increases NFATc1 induction more than RANKL alone as measured by Western
blotting of nuclear extracts. H3, histone 3 antibody. (I) CFU from lysates of WT BMMs treated with Rosiglitazone (ROSI [black bars]) or untreated (-ROSI [white
bars]) at 18 hpi. n 3 biological replicates. **, P 0.01; ***, P 0.001; ****, P 0.0001 by two-way ANOVA with Tukey’s posthoc test (A, C, F, G, and I) or Student’s
t test (B).
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grown on culture-treated plastic, we confirmed similar results in OCs grown and
infected on bone chips in vitro (Fig. S2). Next, to establish whether these observations
were merely an artifact of murine OCs, we infected primary human OCs generated from
peripheral blood CD14 monocytes. Consistent with the data in the mouse system,
human OCs significantly promote intracellular replication of S. aureus (Fig. 2B).
Since the antimicrobial properties of myeloid cells are altered by cytokine exposure,
we sought to determine whether RANKL was unique in its ability to promote intracel-
lular bacterial growth. To address this question, we polarized BMMs for 2 days with
gamma interferon (IFN-), toward an antimicrobial M1 phenotype, or with interleukin
4 (IL-4), toward an M2 phenotype expected to have reduced antimicrobial defense, and
then compared these to RANKL-stimulated BMMs (i.e., pre-OCs). In all cases, levels of
bacteria were similar at 1.5 hpi, indicating consistent internalization (Fig. 2C). IFN-
treatment led to higher levels of killing than observed in control phosphate-buffered
saline (PBS)-treated BMMs, as expected for M1-polarized cells. In the IL-4-stimulated,
M2-polarized cells, we found that S. aureus bacteria are present at the same levels 1.5
and 18 hpi, indicating persistence rather than intracellular killing or proliferation. Thus,
RANKL initiates a distinct program that alters the antimicrobial profile of BMMs as they
differentiate toward OCs.
Proliferative capacity of S. aureus within osteoclasts is NFATc1 dependent in
response to RANKL. Having demonstrated that S. aureus proliferates robustly within
differentiated OCs, we next wanted to determine whether deficiency of NFATc1, the
master transcriptional regulator of OC formation, would modulate intracellular bacterial
levels in response to RANKL. To this end, Nfatc1fl/fl mice were mated to an inducible
Mx1-cre transgenic line, and poly(I·C) was used to conditionally delete Nfatc1 1 month
prior to harvest of BMMs (Fig. 2D). Consistent with the critical function of NFATc1
in driving OC differentiation (Fig. 2E), we find that S. aureus was unable to replicate in
NFATc1-deficient cells in response to RANKL stimulation (Fig. 2F, D2 condition). In
contrast, we found no difference in the microbial load between unstimulated control
and NFATc1-deficient BMMs, a result consistent with the low basal expression of
NFATc1 in the absence of RANKL (Fig. 2D).
Because we found that RANKL-induced NFATc1 promotes intracellular replication of
S. aureus, we evaluated whether forced expression of this molecule would further
enhance microbial expansion. For this purpose, we cloned Nfatc1 cDNA into the pMX
retroviral vector and transduced wild-type (WT) BMMs. After blasticidin selection,
transduced cells were cultured with macrophage colony-stimulating factor (M-CSF)
alone or under osteoclastogenic conditions and challenged with S. aureus. Using this
gain-of-function approach, we demonstrate that ectopic expression of NFATc1, which
accelerates OC differentiation, significantly increased microbial burden compared to
cells transduced with empty vector under osteoclastogenic conditions (Fig. 2G). Sur-
prisingly, overexpression of NFATc1 in BMMs, in the absence of RANKL signaling, failed
to support replication, as the microbial loads were comparable to those of the empty
vector control. Similarly, treatment with rosiglitazone, a peroxisome proliferator-
activated receptor- agonist that augments RANKL-induced NFATc1 levels when com-
bined with RANKL (Fig. 2H), led to a significant increase in intracellular microbial
accumulation relative to untreated OCs (Fig. 2I). However, in the absence of RANKL,
NFATc1 expression was not induced, and intracellular microbial counts were compa-
rable between rosiglitazone-treated and untreated BMMs (Fig. 2I). Thus, using both
genetic and pharmacological approaches, intracellular proliferation of S. aureus within
OCs is NFATc1 dependent in response to RANKL stimulation.
Alternative NF-B promotes intracellular expansion of S. aureus. Although our
data demonstrate a clear role for NFATc1 in facilitating intracellular growth of S. aureus
in OCs, we found that microbial burden was unaltered in NFATc1-overexpressing BMMs
compared to empty vector controls, suggesting that other RANKL-induced signaling
pathways are also essential for the effect. Previously, our group has demonstrated that
the alternative NF-B signaling pathway is highly upregulated by RANKL stimulation
S. aureus Proliferates within Osteoclasts ®
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and promotes OC formation (34, 35, 40). In order to investigate the importance of
alternative NF-B signaling in promoting S. aureus intracellular expansion, we utilized
cells deficient in the alternative NF-B central upstream kinase NIK or the downstream
transcription factor RelB. Loss of either NIK or RelB significantly decreases the ability of
S. aureus to replicate intracellularly (Fig. 3A and B).
NFATc1 levels are significantly reduced with RelB deficiency, and retroviral overex-
pression of NFATc1 can rescue deficient OC formation that results from the loss of RelB
(35). Therefore, we next determined whether ectopic expression of NFATc1 could
restore the ability of S. aureus to replicate in RelB-deficient cells. Restoration of NFATc1
to empty vector WT levels rescued osteoclastic differentiation (Fig. 3C and D), and this
resulted in the restoration of the microbial burden to empty vector WT levels in RelB
knockout cells under osteoclastogenic conditions (Fig. 3E). These data highlight the
importance of alternative NF-B and NFATc1 signaling in mediating intracellular S.
aureus replication.
S. aureus can proliferate within individual OCs to varying degrees. The preced-
ing experiments show that OCs can permit the growth of S. aureus in a RANKL-induced,
osteoclastogenic-dependent manner at the population level (CFU assay). In order to
monitor the bacteria within individual OCs over time, we utilized time-lapse fluores-
cence microscopy to visualize OCs infected with GFP-positive (GFP) S. aureus. Mon-
FIG 3 Alternative NF-B in OCs promotes intracellular S. aureus replication in vitro. (A and B) BMMs harvested from NIK
knockout mice (Nik/ [black bars]) (A) and RelB knockout mice (Relb/ [black bars]) (B) were differentiated into OCs for
0, 2, or 3 days and subjected to the gentamicin protection assay. CFU of intracellular S. aureus proliferation were examined
at 18 hpi. (C) TRAP-stained images of WT or Relb/ BMMs transduced with empty vector (EV) or NFATc1-overexpressing
virus (NFAT) and differentiated for 48 h. (D) Western blot of NFATc1 protein expression from WT or Relb/ (KO) BMMs
transduced with EV or NFAT and differentiated with RANKL for 0 (D0) or 2 (D2) days. (E) WT or Relb/ (KO) cells transduced
with EV or NFAT virus, differentiated in RANKL for 3 days, infected with S. aureus, and subjected to the gentamicin
protection assay. Bars represent CFU of lysates at 18hpi. n 3 biological replicates. Statistical significance: in panels A and
B, ****, P  0.0001 by two-way ANOVA with Tukey’s posthoc test; in panel E,**, P  0.01; ****, P  0.0001 by one-way
ANOVA with Tukey’s posthoc test.
Krauss et al. ®
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itoring three representative OCs over the course of 10 to 12 h, the GFP signal clearly
increases with time (Fig. 4A, white arrows; see also Movie S1 in the supplemental
material). Interestingly, the growing clusters of GFP bacteria do not appear to
colocalize with phagolysosomes but rather seem to localize within inclusion vesicles
that are devoid of LysoTracker staining (Fig. 4A, insets). Next, in order to transcend
limitations in resolution and scope inherent to the time course examination of single,
infected cells, we utilized flow cytometry to further explore the fate of GFP-labeled S.
aureus within each cultured cell after internalization. BMMs or pre-OCs grown in RANKL
for 2 days were infected at an MOI of 1:1, extracellular bacteria were killed with
gentamicin as before, and then cells were fixed at 2 or 18 hpi. At this low MOI, a
minority of cells bear detectable levels of GFP bacteria at 2 hpi, and the levels are
similar for BMMs and pre-OCs (Fig. 4B and C), as we observed in the bulk CFU assay
FIG 4 S. aureus proliferates within individual OCs to different magnitudes. (A) Images depict representative OCs infected with GFP S. aureus (green) and
lysosomes labeled with LysoTracker (red). Outlines indicate cell boundaries. White arrows track the formation of intracellular GFP S. aureus within vesicles over
the indicated time frames. Insets represent higher magnified images of enumerated white boxes. Bars 20 m and 5 m within image and insert panels,
respectively. (B) Offset histogram of flow cytometric data from infected cells differentiated in RANKL for 0 or 2 days and then infected with GFP S. aureus at
an MOI of 1:1. Infected cells were detected by an increased signal in the FITC channel. The threshold for FITC is depicted by the dashed line, based on cells
infected with GFP-labeled bacteria. n 3 biological replicates. (C) Infected cells (GFP) are shown as a percentage of total cells, as measured via flow cytometry.
(D) Mean fluorescence intensity (MFI) as measured from the FITC fraction of cells via flow cytometry. **, P  0.01; ****, P  0.0001 by two-way ANOVA with
Tukey’s posthoc test. (E) Transmission electron micrograph of dividing S. aureus in a membrane-bound compartment inside an OC.
S. aureus Proliferates within Osteoclasts ®
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(Fig. 2A and C). By 18 hpi, the fraction of GFP BMMs decreased similar to previous
observations, although it did not reach statistical significance. There was no statistically
significant change in the percentage of GFP D2 pre-OCs at 18 hpi, although there was
higher variability between biological replicates. Very few bacteria were detected in the
culture media at 12 to 18 hpi, suggesting it is unlikely that cell lysis and new infection
of adjacent cells occur at high enough frequencies to affect our readouts (see Table S1
in the supplemental material). We next plotted the mean fluorescence intensity (MFI) of
the GFP populations in each culture (Fig. 4D). There was no change in the BMMs with
time, suggesting that the few cells that were unable to clear bacteria nevertheless
restrained their growth. In contrast, the MFI of GFP pre-OCs increased approximately
fourfold between 2 and 18 hpi, indicating a greater number of bacteria per cell at the
later time point. Further, the histogram (Fig. 4B) shows a population of pre-OCs at 18
hpi with a very high MFI (up 100- to 500-fold) compared to any other culture condition.
Supporting our conclusion that the bacteria are expanding within RANKL-treated cells,
transmission electron microscopy demonstrates dividing bacteria in mature OCs at 18
hpi (Fig. 4E). Taken together, the time-lapse imaging and flow cytometry data demon-
strate that S. aureus is able to proliferate within individual OCs. Furthermore, the flow
cytometry data suggest that a subset of pre-OCs permits the rapid intracellular prolif-
eration of bacteria to a far greater degree than the majority of pre-OCs.
S. aureus within osteoclasts is not located exclusively in phagolysosomes.
Because the optical resolution is limited for live cell images, we further evaluated the
apparent phagolysosome avoidance by S. aureus in OCs with endpoint confocal
microscopy at 18 hpi, using GFP bacteria and LysoTracker red staining. Three-
dimensional reconstructions show a modest amount of GFP S. aureus inside the cell
imaged at 2 hpi (Fig. 5A, top), whereas the amount is higher in the cell imaged at 18
hpi (Fig. 5A, bottom). We see similar results when OCs are grown and infected on bone
slices (Fig. 1 and Fig. S3). However, analogous to the wide range in fluorescence
intensity of infected D2 pre-OCs demonstrated by flow cytometry (Fig. 4B), the number
of bacteria in each mature OC was variable across the entire population in a particular
culture. There are numerous examples of bacteria not colocalizing with phagolyso-
somes (Fig. 5A to C, white arrows and insets). Interestingly, in cells with a low bacterial
load (Fig. 5C, box 1), there appears to be a high degree of colocalization between the
bacteria and phagolysosomes (Fig. 5C and D). Comparatively, cells harboring very large
clusters of bacteria (Fig. 5B and C, boxes 2 and 3) seem to have more bacteria that do
not appear to reside in acidified phagolysosomal compartments (Fig. 5C), although the
degree varies. In order to quantify the colocalization of the fluorescent signal peaks
from the green GFP bacteria with the red LysoTracker-stained phagolysosomes, we
evaluated the Pearson’s colocalization correlation coefficients (Rr) generated from line
scans taken within each cell (Fig. 5C and D). Using the Pearson’s coefficients (Rr)
generated from multiple OCs (20 to 30 per field, per experiment, over three experi-
ments), we find that OCs separate into three categories of colocalization between S.
aureus and phagolysosome staining. About 60% of OCs exhibit a strong degree of
colocalization, while the other 40% exhibit only a moderate (30%) or partial (10%)
colocalization (Fig. 5E). These data suggest phagolysosomal evasion or destruction as
potential mechanisms underpinning S. aureus intracellular proliferation within OCs.
Furthermore, as both flow cytometry and confocal microscopy show a small percentage
of OCs with very high bacterial loads, it is possible that a subpopulation of OCs is
responsible for the majority of S. aureus proliferation observed at the population level.
DISCUSSION
OM is a common and debilitating infection, with associated osteolysis causing pain
and pathological fractures. To this point, most of the work examining OCs in the
context of OM has focused on the stimulatory effect of S. aureus on OC activity. In this
study, we utilized a low multiplicity of infection (MOI) of 1 to 10 which may reveal
host-pathogen interactions that are masked by much higher bacterial loads, as different
S. aureus inocula have been shown to have differential effects on the immune response
Krauss et al. ®
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FIG 5 Significant percentage of OCs do not have high S. aureus colocalization with lysosomes. Confocal microscopy images of OCs at 2 or 18 h
after being infected with GFP S. aureus. (A and B) Images show GFP S. aureus (green), lysosomes (LysoTracker, red), F-actin (turquoise), and
(Continued on next page)
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and infection progression (41). With this approach, we have shown that OCs are a target
of S. aureus infection, in vivo and in vitro, providing the bacteria a replicative niche.
Unlike their progenitors, OCs are unable to completely confine internalized S. aureus to
phagolysosomes, the likely cause of their failure to eliminate the bacteria. Thus, the
direct interactions between OCs and S. aureus may play an important role in the
progression of OM beyond bone loss, affecting the survival and proliferation of the
pathogens.
The ability of S. aureus to proliferate after internalization was dependent on prior
RANKL stimulation of the host cell for 2 days, the point at which cells become positive
for TRAP and are considered to be committed to the OC lineage. Complete differen-
tiation into multinucleated OCs, whether on plastic or bone, was associated with an
even higher level of intracellular bacteria. The effect of RANKL was unique, as polar-
ization of the BMMs toward M2 macrophages with IL-4, which causes reduced bacterial
killing, did not allow intracellular replication. Since osteoclastogenesis depends on
NFATc1, it is not surprising that this transcription factor was also required for the effect
of RANKL on S. aureus. Interestingly, overexpression of NFATc1 alone, which is not
sufficient to cause OC differentiation, did not promote bacterial proliferation without
concomitant RANKL exposure. This suggests that additional signals from RANKL/RANK
are required. The alternative NF-B pathway is activated by RANKL and is upstream of
NFATc1 and other factors important for OC function (35). Deficiency of NIK, the apex
kinase, results in a more severe impairment in OC differentiation relative to genetic
disruption of RelB, the key transcriptional subunit (35), and likewise NIK ablation blunted S.
aureus proliferation more than RelB deficiency. Furthermore, restoration of NFATc1 expres-
sion in the RelB-deficient background to WT levels also normalized both OC differentiation
and bacterial loads, suggesting that in this context, NFATc1 activation is the primary
mediator of bacterial handling. These data are especially interesting in light of findings from
others that elucidate the importance of RANKL signaling in driving osteoclast-mediated
inflammatory bone resorption (42). Overall, these findings bolster our conclusion that
RANKL-induced osteoclastogenesis is necessary for the increased bacterial replication, and
they add to the rigor of our studies as we have shown consistent results across different
mouse colonies, genetic knockouts, and treatments.
By using a low MOI, we observed cellular heterogeneity within our cultures in both
the D2 pre-OCs as well as in mature OCs. By using flow cytometry, we were able to
identify the small percentage of cells that actually became infected with S. aureus and
then monitor the cultures over time. Since the fraction of infected cells did not change
between 1.5 and 18 hpi, the increase in fluorescence represents bacteria replicating
within previously infected cells, and not replication in the media and infection of new
cells. We also found that among this infected population there was a subset of cells that
allowed the replication of bacteria to a much greater extent than other cells, as
reflected by the “tail” of cells with a high MFI only at 18 hpi in D2 pre-OCs. In fact, this
minority population of cells could be responsible for the more than 2-log10-unit
increase in bacteria represented in the MFI by flow cytometry and CFU in the antibiotic
protection assays. It is possible that differences in bacterial expansion within the
pre-OCs at D2 are related to the degree of differentiation, since these primary cell
cultures are somewhat heterogeneous. However, a similar variability in bacterial load
was seen by confocal microscopy in mature OCs.
As OCs are differentiated from BMMs, it is important to compare the consequences
of bacterial internalization between the two cell types in order to understand how OCs
fail where BMMs succeed. Although S. aureus has been shown to be able to replicate
FIG 5 Legend (Continued)
nuclei (blue) within OCs. Enumerated inserts represent higher magnified images (C). (D) The cross-correlation analysis of the peaks of green (S.
aureus) and red (LysoTracker) fluorescence intensity from the line scans (C1 to C3, white lines) is represented with the corresponding Pearson’s
coefficient (Rr). (E) A bar graph depicting the percentage of OCs exhibiting either a strong, moderate, or partial degree of GFP S. aureus-
LysoTracker colocalization as based on their respective Pearson’s coefficient (Rr). n 3 biological replicates with 20 to 30 OCs counted per field.
Bars 10 m.
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within human macrophages (37, 38), typically murine BMMs effectively destroy inter-
nalized bacteria via phagolysosome acidification. For S. aureus, this is a process involv-
ing NLRP3 inflammasome activation and caspase-1 cleavage that leads to NADPH
oxidase 2 (NOX2) production of reactive oxygen species (36). We discovered that
mature multinucleated OCs exhibited different degrees of colocalization of S. aureus
with phagolysosomes, and interestingly, the OCs with the highest intracellular bacterial
loads had the lowest degree of S. aureus colocalization with phagolysosomes. By
time-lapse fluorescence microscopy, we detected S. aureus in clusters only, and these
were within vacuoles that excluded LysoTracker staining, likely representing the cells
with the highest bacterial loads. It is possible that the10% of OCs we found with only
a partial degree of GFP S. aureus-phagolysosome colocalization also coincide with the
subset of pre-OCs with very high GFP bacterial load via flow cytometry. Our initial
ultrastructural investigation using transmission electron microscopy showed that di-
viding S. aureus can be found in membrane-bound compartments, but the bacterial
load in the visualized cells was relatively low compared to most seen on confocal
microscopy. Therefore, it is possible that bacteria replicate in the cytoplasm as well.
Although under our experimental conditions, lysis of OCs is uncommon before 18 hpi,
it becomes frequent by 24 hpi. Future work will focus on tracing the intracellular fate
of the bacteria within OCs over time, including defining the endosomal compartments
involved and whether they escape into the cytoplasm prior to cell death. Additional
single-cell approaches will be required to determine which host cell pathways deter-
mine the fate of intracellular S. aureus and whether these are responsible for the
observed differences between cells.
Ultimately, this work elucidates a new role for OCs in propagating infectious OM, at
least in the context of S. aureus. It has previously been shown that osteoblasts release
proosteoclastogenic cytokines, including RANKL, that recruit and activate OCs at the
site of infection. While others have shown that S. aureus and its cellular components can
promote osteoclastogenesis, OC activity, and proinflammatory cytokine release (29, 32,
43), this investigation focused on determining the infectibility of OCs. We found that it
is possible for OCs to become infected and provide a replicative niche for S. aureus to
proliferate and evade immune destruction and that this whole process is dependent on
RANKL signaling. Although the influence of S. aureus on OC activity and cytokine
production is undoubtedly important for the progression of OM lesions, we have
extended the potential role for these cells to include bacterial expansion. If S. aureus
promotes OC recruitment and formation and OCs can harbor bacteria from destruction,
then these conditions can form a positive-feedback loop. Thus, therapies aimed at
modulating the ability of OCs to shelter bacteria might provide increased efficacy in
curing these difficult-to-treat infections.
MATERIALS AND METHODS
Reagents. Trypticase soy broth was procured from Fisher Scientific (Hampton, NH, USA). Fetal bovine
serum (FBS) and gentamicin (catalog no. 15750060) were purchased from Gibco-BRL (Grand Island, NY,
USA). -Minimal essential medium (-MEM), anti--actin (A2228) antibody, rosiglitazone, polyinosinic-
poly(C) [poly(I·C)], and lysostaphin (L7386) were all purchased from Sigma-Aldrich (St. Louis, MO, USA).
Macrophage colony-stimulating factor (M-CSF), in the form of CMG 14-12 supernatant, and glutathione
S-transferase RANKL (GST-RANKL) were prepared as previously described (33). Human M-CSF and Ficoll
histopaque were purchased from Invitrogen (Carlsbad, CA, USA). Human CD14 magnetic beads were
obtained from Miltenyi Biotec (Auburn, CA, USA). Anti-NFATc1 (7AG) antibody was obtained from Santa
Cruz Biotechnology (Dallas, TX, USA), and anti-histone H3 (96C10) was obtained from Cell Signaling
Technology (Beverly, MA, USA). Murine recombinant IL-4 and IFN- were purchased from Peprotech
(Rocky Hill, NJ, USA).
Mice. C57BL/6 male and female mice (8 to 10 weeks old) were purchased from The Jackson
Laboratory (Bar Harbor, ME, USA). Relb/ and Nik/ mice and their littermate controls were generated
by heterozygotic mating of Relb/ and Nik/ mice, respectively, in a specific-pathogen-free facility as
previously described (34, 40). TRAP promoter-tdTomato (TRAPRed) transgenic mice were generated by M.
Ishii (Immunology Frontier Research Center, Osaka University, Osaka, Japan [39]), provided by J. Lorenzo,
and maintained by heterozygotic mating in our specific-pathogen-free facility. Conditional knockout
Nfatc1 (Nfatc1 cKO) mice were provided by Julia Charles (Harvard Medical School, Boston, MA) and
generated by crossing Nfatc1 fl/flmice with a transgenic line expressing the Cre recombinase from a type
I interferon-inducible promoter (Mx1-Cre) as previously described (44). Activation of Mx1-Cre was
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achieved by intraperitoneal injection of 0.25 ml of 1 mg/ml poly(I·C) in phosphate-buffered saline (PBS)
every other day. Three rounds of injections were given, followed by a 3-week waiting period to ensure
optimal Nfatc1 deletion. Littermates lacking the Mx1-Cre transgene were treated identically with poly(I·C)
and served as NFATc1-sufficient (Nfatc1fl/fl) controls. For all experiments employing genetically modified
mice, results were compared to cells from sex/age-matched littermate controls.
Osteoclast culture. To generate osteoclasts (OCs) from enriched bone marrow macrophages
(BMMs), bone marrow was harvested from the long bones of 10- to 12-week-old mice, and cells were
cultured in -MEM plus 10% FBS and a 1:10 dilution of CMG 14-12 cell supernatant (containing the
equivalent of 100 ng/ml of M-CSF) for 4 days to expand BMMs. Nonadherent cells were removed by
several washes in PBS, and adherent BMMs were detached with trypsin-EDTA, seeded into tissue-cultured
treated plates and cultured in -MEM plus 10% FBS containing a 1:50 dilution of CMG 14-12 cell
supernatant (containing the equivalent of 20 ng/ml of M-CSF) and GST-RANKL (60 ng/ml) with medium
changes every day for the indicated time periods.
For human osteoclastogenesis, peripheral blood mononuclear cells were obtained by density gra-
dient centrifugation with Ficoll histopaque. Monocytes were isolated using anti-CD14 magnetic beads
according to the manufacturer’s instructions. Human CD14 cells were seeded into six-well plates at a
seeding density of 1 106 cells per well. Monocyte-derived osteoclasts were generated by culturing
CD14 cells for 6 days in -MEM plus 10% FBS containing 20 ng/ml of human M-CSF and GST-RANKL. The
medium was changed and cytokines were replenished every other day.
Bacterial strains and growth conditions. All experiments were conducted with derivatives of
Staphylococcus aureus USA300 clinical isolate LAC (45). Bacterial strains were grown in Trypticase soy
broth (TSB) overnight at 37°C with shaking at 225 rpm, subcultured at a dilution of 1:100, grown to
mid-exponential phase (optical density at 600 nm [OD600] of 1.0), and centrifuged at 3,000 rpm for 10
min. The pellets were washed and resuspended with PBS to the desired concentration. To create a stable
GFP strain of S. aureus, the region containing the sarA promoter driving superfolder GFP (sfGFP) was
first amplified out of pCM11 (46) using primers 5=-GTTGTTTCTAGACTGATATTTTTGACTAAACCAAATG-3=
and 5=-GTTGTTGAGCTCTTAGTGGTGGTGGTG-3= (restriction sites underlined). The resulting PCR amplifi-
cation product was then ligated into the XbaI and SacI sites of pJC1111 to create pNP1. pNP1 was then
chromosomally integrated into the SaPI1 site of S. aureus as previously described (47). The region
encompassing the chromosomal SaPI1 integration was then transduced into S. aureus strain LAC
(AH1263) (45) using phi80a. Integration of PsarA_sfGFP at the SaPI1 site was confirmed using primers
JCO717 and 719 (47).
Antibiotic protection assays. Infection of BMMs and OCs by S. aureus was quantified by determin-
ing the number of CFU recovered from antibiotic treatment using a gentamicin protection assay as
previously described (37, 38, 48). Briefly, cells were seeded at 5 105/well in six-well plates and cultured
in -MEM plus 10% FBS containing a 1:50 dilution of CMG 14-12 cell supernatant (containing the
equivalent of 20 ng/ml of M-CSF) in the presence or absence of GST-RANKL for the designated time of
osteoclastic differentiation as described above. To determine the level of intracellular survival, the cells
were infected for 30 min at an MOI of 1:1 (final dose of 5 105/well) at 37°C in 5% CO2, washed twice
in PBS, and cultured in media (-MEM plus M-CSF with or without RANKL) containing antibiotic
(gentamicin at a final concentration of 0.3 mg/ml or lysostaphin at a final concentration of 20 g/ml) for
1 h to kill extracellular bacteria. Cells were washed twice in PBS to remove antibiotic and lysed in sterile,
ice-cold ultrapure H2O for the 1.5 h time point (1.5 hpi). For the 18 h time point (18 hpi), culture media
(-MEM plus M-CSF with or without RANKL) were replaced after PBS washes, and infection was continued
to 18 h postinfection prior to hypotonic lysis as described above. Lysates were 10-fold serially diluted,
plated on TSB solidified with 1.5% agar (TSA), and incubated overnight at 37°C, and CFU were
enumerated. Controls for antibiotic killing of S. aureus were included in all experiments by plating
supernatant on TSA and inspecting for colonies after overnight incubation at 37°C.
Flow cytometric assays. For flow cytometry, cells were seeded at 5 105/well in six-well tissue
culture treated plates, as described above. Cells were challenged with GFP-expressing S. aureus at an MOI
of 1:1 for 30 min, and the extracellular bacteria was killed by the addition of gentamicin to the media for
1 h. Cells were washed twice in PBS to remove antibiotic, and then the medium was replenished. The
cells were then harvested at 2 h (2 hpi) or 18 h (18 hpi). Cells were detached with trypsin-EDTA and
washed twice in PBS to remove nonadherent bacteria, and extracellular fluorescence (reflecting attached
but uninternalized bacteria) was quenched with 0.2% trypan blue as previously described (48) Cells were
washed twice in PBS, fixed in 90% methanol for 30 min at 4°C, and analyzed via flow cytometry (percent
fluorescein isothiocyanate [FITC]-positive cells and mean fluorescence intensity of FITC-positive popula-
tion), using a BD LSR-II flow cytometer in PBS containing 2 mM EDTA and 2% FBS. The data were analyzed
using Flow Jo v 10.5.3.
Confocal microscopy. Laser scanning confocal microscopy of mouse calvaria was performed to
assess microbial uptake by osteoclasts in vivo. Prior to infection, RANKL (2 mg/kg body weight) was
injected over the periosteum of calvaria of TRAPRed reporter mice once a day for 5 days. Subsequently,
107 GFP-expressing S. aureus bacteria were suspended in 100 l PBS and subcutaneously injected over
the periosteum of the calvaria. At 24 h postinfection, calvariae were harvested, fixed overnight in 4%
paraformaldehyde at room temperature, and washed six times with PBS in 15-min intervals. Calvariae
were next decalcified in 14% free acid EDTA for 3 days under continuous agitation, infiltrated in 30%
sucrose overnight at 4°C, followed by embedding in OCT medium and cut into 10-m-thick sections in
a coronal orientation. Tissue sections were then mounted in Prolong Gold Antifade with 4=,6=-diamidino-
2-phenylindole (DAPI) and cured for 48 h. For imaging of in vivo bacterial uptake, optical sectioning was
performed by using Nikon A1RSi confocal microscope (Nikon Instruments Inc., NY, USA). Images were
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collected using an oil immersion 100 objective lens (CFI Plan Apo Lambda 100 Oil; Nikon Instruments
Inc.) with 0.5-m z-steps. For each mouse, 15 to 20 optical sections were captured in 8 to 10 different
regions of interest from five separate tissue sections. Lasers with wavelengths of 405, 488, and 561 nm
were used to excite fluorescence from DAPI, GFP, and tdTomato reporter probes. Line averaging and
sequential scanning were employed to increase the signal-to-noise ratio and minimize spectral bleed-
through, resulting in a frame acquisition time of 16 s/frame. Background subtraction was carefully utilized
to reduce the contribution of tissue autofluorescence. Images were processed in Nikon NIS-Elements
(Nikon Instruments Inc.) and Fiji (49).
Murine bone marrow macrophage (BMM)-derived OCs differentiated on glass coverslips or devital-
ized bovine bone discs were incubated with GFP-expressing S. aureus (MOI of 10) followed by gentamicin
as described above and cultured for a total of 18 h. To monitor for bacterial incorporation into
phagolysosomes, OCs were further incubated with the acidotrophic probe Lysotracker Red DND-99
(100 nm; Invitrogen) for 30 min prior to fixation. Cells were fixed in 4% paraformaldehyde (PFA) in PBS
for 15 min at room temperature (RT), permeabilized with 0.1% Triton X-100, and stained with Alexa Fluor
647-conjugated phalloidin (1:500) and Hoechst 33258 dye (1:10,000) (Invitrogen) to visualize F-actin and
nuclei, respectively. Samples were then mounted in ProLong Gold Antifade (Thermo Fisher Scientific Co.)
and imaged using a Nikon A1RSi confocal microscope, equipped with a 10 (dry) lens and 60 (oil
immersion) lens (Nikon Instruments Inc., NY, USA). Images were collected using the Nikon NIS-C Elements
software. Cross-correlation analysis (Pearson’s, Rr) of colocalization between bacteria and phagolyso-
somes was performed using online ImageJ macros (NIH). To quantify the percentage of OCs with
different GFP S. aureus-lysosome colocalization, infected OCs were enumerated from three individual
experiments with 20 to 30 OCs counted per field. The three groups (strong, moderate, and partial) refer
to the amount of colocalization as measured by their Pearson’s Rr coefficient values as follows: strong,
Rr 0.85; moderate, Rr 0.7 to 0.85; and partial, Rr 0.55 to 0.7.
Time-lapse confocal microscopy images were obtained of live BMM-differentiated OCs infected with
GFP S. aureus for 30 min and following killing of extracellular bacteria by the addition of gentamicin
to the media for 1 h. Cells were washed twice in PBS to remove antibiotic, and medium was replenished.
Cells were subsequently incubated with LysoTracker red for 30 min, and the medium was refreshed and
then imaged under controlled atmospheric conditions (37°C and 5% CO2) in a Tokai Hit (Fujinomiya,
Japan) Stage Top Incubator (INUG2E-TIZ) for up to 18 h by time-lapse confocal microscopy (Nikon A1RSi)
using a 20 (dry) objective lens.
Immunoblotting. Cells were washed twice on ice with cold PBS and lysed in radioimmunoprecipi-
tation assay (RIPA) buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100,
2.5 mM sodium pyrophosphate, 1 mM -glycerophosphate, 1 mM Na3VO4, 1 mM NaF) containing Halt
protease cocktail inhibitor (Thermo Scientific, Rockford, IL, USA). After 10-min incubation on ice, lysates
were centrifuged at 16,000 g to pellet cellular debris, and protein concentration was determined by
bicinchoninic acid (BCA) quantification assay (Bio-Rad, Hercules, CA, USA). For each sample, 30 g of total
lysate was resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
semidry transferred to a polyvinylidene difluoride (PVDF) membrane. Membranes were blocked for 1 h
in 5% milk in Tris-buffered saline (TBS) containing 0.1% Tween and probed with respective primary
antibodies overnight at 4°C with continuous agitation, followed by 1-h incubation at room temperature
with secondary HRP-conjugated antibodies. Proteins were detected using WesternBright Quantum HRP
substrate (Advansta, Menlo Park, CA, USA) and visualized with Genesnap using the Syngene Imaging
System (Synoptics, Frederick, MD, USA).
Retroviral transduction. NFATc1-pMX construct was transiently transfected into Plat-E packaging
cells by calcium phosphate precipitation method as previously described (35, 50). Viral supernatant was
harvested 48 h posttransfection and used to infect BMMs for 48 h in the presence of M-CSF equivalent
(20 ng/ml) and 4 g/ml Polybrene, followed by selection in blasticidin for 3 days before culture with
20 ng/ml M-CSF equivalent and GST-RANKL (30 ng/ml).
Statistical analysis. All data were represented as means with standard deviation. Comparisons
between groups of the CFU from human OCs (Fig. 2B) were analyzed by Student’s t test. Comparisons
between groups of CFU from 18 hpi OCs from different days of RANKL treatment (Fig. 1D) or NFATc1
overexpression (Fig. 4E) were analyzed by one-way analysis of variance (ANOVA) with Tukey’s multiple-
comparison posthoc test (GraphPad InStat). All other data analyzed by two-way ANOVA with Tukey’s
multiple-comparison posthoc test, and P  0.05 was taken as significant.
Ethics statement. All animal procedures were approved by Washington University Institutional
Animal Care and Use Committees (IACUC protocol 20170025), in compliance with the established federal
and state policies outlined in the Animal Welfare Act (AWA) and enforced by the U.S. Department of
Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS), USDA Animal Care.
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